On the recordJuly 6, 2011
I was concerned about some of the restrictions that this committee placed on the advisory panels that advise the FDA about the approval or non-approval of drugs and devices.
Source
congress.govEditor's note · Context
Burgess expresses concern over restrictions on FDA advisory panels affecting drug approvals.
Share & report
More from Michael Burgess
Jul 24, 2024
Mr. Speaker, I yield 5 minutes to the gentleman from Pennsylvania (Mr. Kelly), the sponsor of this resolution.
Jul 24, 2024
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, on the afternoon of July 13 in Butler, Pennsylvania, a 20-year-old man walked across a barren field just outside a rally for Donald Trump with a rifle, a transponder, and…
Sep 24, 2024
Madam Speaker, last night, the House Committee on Rules met to report House Resolution 1486, providing for the consideration of four pieces of legislation. First, the rule provides for consideration of H. Res. 1469, condemning the…
Jul 24, 2024
Mr. Speaker, honestly, I keep hearing the term ``MAGA'' used by the other side. I am referred to as MAGA. You keep saying that word. I don't think you know what it means. It is an acronym that stands for Make America Great Again. I don't…
Other voices in this conversation
